Researchers mark milestone in progress toward investigational new drug for triple-negative breast cancer
A new compound developed by researchers at MUSC Hollings Cancer Center shows promise in overcoming chemotherapy resistance in triple-negative breast cancer—and could potentially be applied to fibrotic conditions like liver ...
Jul 22, 2024
0
57
